SI
NARI

Sofinnova Investments’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Sofinnova Investments’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-180,456
Closed -$9.21M – 81
2024
Q4 		$9.21M Buy
180,456
+90,129
+100% +$4.43M 0.67% 34
2024
Q3 		$3.73M Sell
90,327
-65,511
-42% -$3.15M 0.3% 45
2024
Q2 		$7.5M Buy
155,838
+145,622
+1,425% +$6.45M 0.39% 49
2024
Q1 		$490K Buy
+10,216
New +$546K 0.03% 67

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Sofinnova Investments's NARI Position: Q1 2025 in Review

Sofinnova Investments sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 180,456 shares — an estimated $9.21M sold.

Sofinnova Investments first reported a position in NARI in Q1 2024 and held it in 4 quarters. The position peaked at $9.21M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Sofinnova Investments reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Sofinnova Investments sold 180,456 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $9.21M.
  • Sofinnova Investments first reported a position in Inari Medical, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
  • Sofinnova Investments's Inari Medical, Inc. Common Stock position peaked at $9.21M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Sofinnova Investments's 13F filing for Q1 2025, filed 15 May 2025.